The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial

U.S. Renal Data System, USRDS 2008 Annual Data Report, 2009 Lowrie, 1981, Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study, N Engl J Med, 305, 1176, 10.1056/NEJM198111123052003 Eknoyan, 2002, Effect of dialysis dose and membrane flux in maintenance hemodialysis, N Engl J Med, 347, 2010, 10.1056/NEJMoa021583 Unruh, 2004, Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study, Kidney Int, 66, 355, 10.1111/j.1523-1755.2004.00738.x Rocco, 2004, The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO Study, Kidney Int, 65, 2321, 10.1111/j.1523-1755.2004.00647.x Suri, 2006, Daily hemodialysis: a systematic review, Clin J Am Soc Nephrol, 1, 33, 10.2215/CJN.00340705 Walsh, 2005, A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life, Kidney Int, 67, 1500, 10.1111/j.1523-1755.2005.00228.x Chan, 2002, Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis, Kidney Int, 61, 2235, 10.1046/j.1523-1755.2002.00362.x Chan, 2005, Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease, Kidney Int, 68, 338, 10.1111/j.1523-1755.2005.00411.x Pierratos, 1999, Nocturnal home hemodialysis: an update on a 5-year experience, Nephrol Dial Transplant, 14, 2835, 10.1093/ndt/14.12.2835 Lockridge, 2004, Nightly home hemodialysis: five and one-half years of experience in Lynchburg, Virginia, Hemodial Int, 8, 61, 10.1111/j.1492-7535.2004.00076.x Mucsi, 1998, Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis, Kidney Int, 53, 1404, 10.1046/j.1523-1755.1998.00875.x Hanly, 2001, Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis, N Engl J Med, 344, 102, 10.1056/NEJM200101113440204 Sikkes, 2009, Improved nutrition after conversion to nocturnal home hemodialysis, J Ren Nutr, 19, 494, 10.1053/j.jrn.2009.05.006 Culleton, 2007, Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial, J Am Med Assoc, 298, 1291, 10.1001/jama.298.11.1291 Chertow, 2010, Effects of frequent in-center hemodialysis: the Frequent Hemodialysis Network Daily Trial, N Engl J Med, 363, 2287 Zoccali, 2004, Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression, Kidney Int, 65, 1492, 10.1111/j.1523-1755.2004.00530.x London, 2001, Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study, J Am Soc Nephrol, 12, 2759, 10.1681/ASN.V12122759 Suri, 2007, Frequent Hemodialysis Network (FHN) randomized trials: study design, Kidney Int, 71, 349, 10.1038/sj.ki.5002032 Pipkin, 2010, Recruitment and training for home hemodialysis: experience and lessons from the nocturnal dialysis trial, Clin J Am Soc Nephrol, 5, 1614, 10.2215/CJN.02440310 Rocco, 2011, Baseline characteristics of participants in the Frequent Hemodialysis Network Daily and Nocturnal Trials, Am J Kidney Dis, 57, 90, 10.1053/j.ajkd.2010.08.024 Gotch, 2001, Evolution of the single pool urea kinetic model, Semin Dial, 14, 252, 10.1046/j.1525-139X.2001.00064.x Daugirdas, 2010, Standard Kt/V(urea): a method of calculation that includes effects of fluid removal and residual kidney clearance, Kidney Int, 77, 637, 10.1038/ki.2009.525 Daugirdas, 2004, Factors that affect postdialysis rebound in serum urea concentration, including the rate of dialysis: results from the HEMO Study, J Am Soc Nephrol, 15, 194, 10.1097/01.ASN.0000103871.20736.0C Hemmelgarn, 2003, Adapting the Charlson Comorbidity Index for use in patients with ESRD, Am J Kidney Dis, 42, 125, 10.1016/S0272-6386(03)00415-3 Miskulin, 2001, Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial, Kidney Int, 60, 536, 10.1046/j.1523-1755.2001.00954.x Hays, 2001, The RAND-36 measure of health-related quality of life, Ann Med, 33, 350, 10.3109/07853890109002089 Pitt, 2003, Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study, Circulation, 108, 1831, 10.1161/01.CIR.0000091405.00772.6E Mapes, 2003, Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS), Kidney Int, 64, 339, 10.1046/j.1523-1755.2003.00072.x Craven, 1988, The Beck Depression Inventory as a screening device for major depression in renal dialysis patients, Int J Psychiatry Med, 18, 365, 10.2190/M1TX-V1EJ-E43L-RKLF Kurella, 2004, Cognitive impairment in chronic kidney disease, J Am Soc Geriatrics, 52, 1863, 10.1111/j.1532-5415.2004.52508.x Umans, 1998, Attention and mental processing speed in hemodialysis patients, Am J Kidney Dis, 32, 749, 10.1016/S0272-6386(98)70129-5 Tavel, 2001, Closeout of four phase II Vanguard trials and patient rollover into a large international phase III HIV clinical endpoint trial, Control Clin Trials, 22, 42, 10.1016/S0197-2456(00)00114-8 Hochberg, 1988, A sharper Bonferroni procedure for multiple tests of significance, Biometrika, 75, 800, 10.1093/biomet/75.4.800 Verbeke, 2000, 568 Bock, 2008, Darbepoetin alpha in lower-than-equimolar doses maintains haemoglobin levels in stable haemodialysis patients converting from epoetin alpha/beta, Nephrol Dial Transplant, 23, 301, 10.1093/ndt/gfm579